Antimicrobial properties of amniotic membrane

The human amniotic membrane (AM) possesses anti-inflammatory, antifibrotic and antiangiogenic properties, and these attributes makes it ideal for ocular surface reconstruction procedures.1 2 In addition, the AM also has antimicrobial properties due partly to its anti-inflammatory effects, and also due to secretion of elafin and secretory leucocyte proteinase inhibitor, both of which have antimicrobial actions and act as components of the innate immune system.3 4 It also contains cystatin E, an analogue of cysteine proteinase inhibitors, which has complementary antiviral properties.5 In spite of this, AM transplantation (AMT) is reserved for cases of postinfectious ulcers after an appropriate period of anti-infective treatment when clinical signs are improving.6 This is because the anti-infective properties of AM are non-specific and not considered to be potent enough to be effective in acute infective keratitis; this is the reasoning behind the concept of fortifying AM with antimicrobial drugs to make it a viable therapeutic modality in the setting of active infections of the cornea. Antibiotic-impregnated medical devices such as catheters, bone and cardiac implants have been in use for over a decade.7 8 Various studies have …

[1]  U. Menchini,et al.  Inhibition of viral replication in vitro by antiviral-treated amniotic membrane. Possible use of amniotic membrane as drug-delivering tool , 2010, British Journal of Ophthalmology.

[2]  U. Menchini,et al.  Inhibition of viral replication in vitro by antiviral-treated amniotic membrane , 2009 .

[3]  A. Seifalian,et al.  Properties of the amniotic membrane for potential use in tissue engineering. , 2008, European cells & materials.

[4]  V. Sangwan,et al.  Amniotic membrane transplantation: a review of current indications in the management of ophthalmic disorders. , 2007, Indian journal of ophthalmology.

[5]  A. Bocking,et al.  Expression of natural antimicrobials by human placenta and fetal membranes. , 2007, Placenta.

[6]  U. Menchini,et al.  Antimicrobial Activity of Antibiotic-treated Amniotic Membrane: An In Vitro Study , 2006, Cornea.

[7]  A. Heiligenhaus,et al.  Transplantation of amniotic membrane in murine herpes stromal keratitis modulates matrix metalloproteinases in the cornea. , 2005, Investigative ophthalmology & visual science.

[8]  Jonathan R Edwards,et al.  Effect of Nurse Staffing and Antimicrobial-Impregnated Central Venous Catheters on the Risk for Bloodstream Infections in Intensive Care Units , 2003, Infection Control & Hospital Epidemiology.

[9]  P. Mertl,et al.  Effectiveness of Gentamicin-Impregnated Cement in the Prevention of Deep Wound Infection After Primary Total Knee Arthroplasty , 2003, Infection Control & Hospital Epidemiology.

[10]  A. Heiligenhaus,et al.  Management of acute ulcerative and necrotising herpes simplex and zoster keratitis with amniotic membrane transplantation , 2003 .

[11]  E. Tedeschi-Reiner,et al.  Amniotic membrane transplantation for ocular surface reconstruction. , 2002, Collegium antropologicum.

[12]  M. Batterbury,et al.  Collagen corneal shields. , 2002, Survey of ophthalmology.

[13]  T. Hahn,et al.  Amniotic Membrane Transplantation in Infectious Corneal Ulcer , 2001, Cornea.

[14]  R. Gentz,et al.  Cystatin E is a Novel Human Cysteine Proteinase Inhibitor with Structural Resemblance to Family 2 Cystatins* , 1997, The Journal of Biological Chemistry.

[15]  R. Darouiche,et al.  Antibiotics and prevention of microbial colonization of catheters , 1995, Antimicrobial agents and chemotherapy.

[16]  M. Pfaller,et al.  Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial. , 1991, JAMA.

[17]  U. Pleyer,et al.  Device drug delivery to the eye. Collagen shields, iontophoresis, and pumps. , 1991, Ophthalmology.